Business Wire

SAN DIEGO--(BUSINESS WIRE)-- Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three months ended March 31, 2024 financial results.

Results of Operations

As of March 31, 2024, Revelation had $14.6 million in cash and cash equivalents, compared to $12.0 million as of... (continue reading...)

CAMARILLO, Calif.--(BUSINESS WIRE)-- Salem Media Group, Inc. (OTCQX: SALM) announced today the sale of its principal office in Camarillo, California to Eclipse RE Holdings, LLC for $5.5 million, closing on May 1, 2024. Salem will leaseback the building for five years, an approximate 41,546 square foot building situated on approximately 121,532 (2.79 acres) square feet of CPD zoned land.

ABOUT SALEM MEDIA GROUP:

Salem Media Group is America’s leading multimedia... (continue reading...)

NASHVILLE, Tenn.--(BUSINESS WIRE)-- HCA Healthcare, Inc. (NYSE: HCA), is scheduled to present at the following healthcare conference:

June 5, 2024 at 9:30 am ET at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York, NY.

A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company’s website, www.hcahealthcare.com.

Dates... (continue reading...)

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 CheckMate -73L trial did not meet its primary endpoint of progression-free survival (PFS) in unresectable, locally advanced stage III non-small cell lung cancer (NSCLC). CheckMate -73L evaluated Opdivo® (nivolumab) with concurrent chemoradiotherapy (CCRT) followed by Opdivo plus Yervoy® (ipilimumab) versus CCRT followed by durvalumab in patients with unresectable stage... (continue reading...)

BOSTON--(BUSINESS WIRE)-- American Tower Corporation (NYSE: AMT) today announced that it will participate in the following upcoming investor conferences:

• Wednesday, May 15, 2024, 10:00 a.m. ET – Adam Smith, Senior Vice President, Investor Relations and FP&A, is scheduled to speak at MoffettNathanson’s Media, Internet & Communications Conference in New York, New York.

• Monday, May 20, 2024, 3:10 p.m. ET – Steve Vondran, President and Chief Executive... (continue reading...)